Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis

Haemophilia

Volumn 18, Issue 3, 2012, Pages 369-374

  Olivieri, M ^a   Kurnik, K ^a   Pfluger, T ^b   Bidlingmaier, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arthropathy; Haemophilia A; Haemophilia B; Joint damage; Magnetic resonance imaging; Prophylaxis

Indexed keywords

ADOLESCENT; ADULT; ANKLE INJURY; ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; TREATMENT DURATION;

ADOLESCENT; ANKLE JOINT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; JOINT DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 84860320096     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02682.x     Document Type: Article

References (29)

1. Acharya SS. Hemophilic joint disease - current perspective and potential future strategies. Transfus Apher Sci 2008; 38: 49-55.
2. Rodeghiero F, Tosetto A, Abshire T et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
3. Roosendaal G, van den Berg HM, Lafeber FPJG, Bijlsma JWJ. Blood-induced joint damage: an overview of musculoskeletal research in haemophilia. In: Rodriguez-Merchan EC, Goddard NJ, Lee CA eds. Musculoskeletal Aspects of Haemophilia. Oxford, UK: Blackwell Science, 2000: 18-26.
4. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
5. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
6. Schreiber RR. Musculo-skeletal system - radiological findings. In: Brinkhous KM, Hemker HC eds. Handbook of Hemophilia. New York: American Elsevier Publishing Company, Inc., 1975: 333-70.
7. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004; 10: 280-7.
8. Hakobyan N, Kazarian T, Valentino LA. Synovitis in a murine model of human factor VIII deficiency. Haemophilia 2005; 11: 227-32.
9. Mainardi CL, Levine PH, Werb Z, Harris ED Jr. Proliferative synovitis in hemophilia: biochemical and morphologic observations. Arthritis Rheum 1978; 21: 137-44.
10. Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-902.
11. Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59: 287-305.
12. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153-9.
13. Nuss R, Kilcoyne RF, Geraghty S et al. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000; 6: 162-9.
14. Aledort LM, Lee CA. Coagulation deficiencies: a look to the future. Haemophilia 2006; 12: 531-40.
15. Donadel-Claeyssens S; European Paediatric Network for Haemophilia Management. Current co-ordinated activities of the PEDNET (European paediatric network for haemophilia management). Haemophilia 2006; 12: 124-7.
16. Beeton K, De Kleijn P, Hilliard P et al. Recent developments in clinimetric instruments. Haemophilia 2006; 12(Suppl 3): 102-7.
17. Medical Advisory Board, World Federation of Haemophilia and the International Prophylaxis Study Group. Commentary: magnetic resonance imaging as an evaluative tool in haemophilic arthropathy, on behalf of the Medical Advisory Board, World Federation of Haemophilia and the International Prophylaxis Study Group. Haemophilia 2005; 11: 107-8.
18. Doria AS, Lundin B, Kilcoyne RF et al. Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: expert MRI working group of the International Prophylaxis Study Group. Haemophilia 2005; 11: 245-53.
19. Doria AS, Babyn PS, Lundin B et al. Reliability and construct validity of the compatible MRI scoring system for evaluation of haemophilic knees and ankles of haemophilic children. Expert MRI working group of the International Prophylaxis Study Group. Haemophilia 2006; 12: 503-13.
20. Lundin B, Pettersson H, Ljung R. A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy. Haemophilia 2004; 10: 383-89.
21. Gilbert MS. Prophylaxis: musculoskeletal evaluation. Semin Hematol 1993; 30(Suppl 2): 3-6.
22. Feldman BM, Funk SM, Bergstrom BM et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken) 2011; 63: 223-30.
23. Erlemann R, Wörtler K. Diagnostic imaging of hemophilic osteoarthropathy. Orthopäde 1999; 28: 329-40.
24. Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.
25. Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B. When should prophylactic treatment in patients with haemophilia A and B start? - The German experience. Haemophilia 1998; 4: 413-7.
26. Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM, ESPRIT Study Group. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study). J Thromb Haemost 2011; 9: 700-10.
27. Doria AS. State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future. Haemophilia 2010; 16(Suppl. 5): 107-14.
28. Pergantou H, Platokouki H, Matsinos G et al. Assessment of the progression of haemophilic arthopathy in children. Haemophilia 2010; 16: 124-9.
29. Kurnik K, Bidlingmaier C, Engl W, Chehadeh H, Reipert B, Auerswald G. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia 2010; 16: 256-62.